UPL Corp CEO Mike Frank expects pricing pressure in the post-patent segment to persist in H1 2022 but believes the company is well-positioned to compete after taking actions to manage working capital and inventory. Despite a slight drop in Q4 performance due to oversupply and delayed sales, UPL Corp grew its top line by 16% and EBITDA growth by 10%. Going forward, the company will focus on transitioning its portfolio towards differentiated and sustainable products, including crop protection, seed, and specialty chemicals.